US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

44.85

-1.3100-2.84%

Post-market: 44.80-0.0500-0.11%19:54 EDT

Volume:859.92K

Turnover:38.70M

Market Cap:2.75B

PE:10.60

High:46.06

Open:45.96

Low:44.27

Close:46.16

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Protagonist Therapeutics Inc : Btig Raises Target Price to $82 From $73

THOMSON REUTERS

Truist Securities Adjusts Price Target on Protagonist Therapeutics to $76 From $60, Keeps Buy Rating

MT Newswires Live

Protagonist Therapeutics Shares Rise After Positive Trial Data for Icotronkinra

BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

Protagonist Reports Positive Top Line Results From Phase 2B Study of Icotrokinra

THOMSON REUTERS

Protagonist : Results From Phase 2B Study of Icotrokinra Showing Potential to Transform Treatment Paradigm for Patients With Ulcerative Colitis

THOMSON REUTERS

Protagonist Therapeutics : All Three Doses Met the Primary Endpoint of Clinical Response at Week 12, With a Favorable Safety Profile

THOMSON REUTERS

Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis

ACCESS Newswire

Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.

Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Halozyme (HALO) and Arcturus Therapeutics (ARCT)

Protagonist Therapeutics Is Maintained at Overweight by JP Morgan

Protagonist Therapeutics: Positive VERIFY Trial Results and Promising Financial Prospects Justify Buy Rating

Protagonist Therapeutics price target raised to $73 from $67 at BTIG

News Flash: 10 Analysts Think Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Earnings Are Under Threat

Simply Wall St.

Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.

Protagonist Therapeutics’ Rusfertide: A Promising Blockbuster in the Polycythemia Vera Market with Strong Buy Rating

Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PTGX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","market":"US","secType":"STK","nameCN":"Protagonist Therapeutics","latestPrice":44.85,"timestamp":1745524800000,"preClose":46.16,"halted":0,"volume":859924,"hourTrading":{"tag":"盘后","latestPrice":44.8,"preClose":44.85,"latestTime":"19:54 EDT","volume":117635,"amount":5275858.8571,"timestamp":1745538866686},"delay":0,"floatShares":46016259,"shares":61384289,"eps":4.229999,"marketStatus":"Not Yet Opened","change":-1.31,"latestTime":"04-24 16:00:00 EDT","open":45.96,"high":46.06,"low":44.27,"amount":38700057.532656,"amplitude":0.038778,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.229999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745568000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":46.16,"preHourTrading":{"tag":"盘前","latestPrice":46.01,"preClose":46.16,"latestTime":"09:29 EDT","volume":349,"amount":16092.14919,"timestamp":1745501399999},"postHourTrading":{"tag":"盘后","latestPrice":44.8,"preClose":44.85,"latestTime":"19:54 EDT","volume":117635,"amount":5275858.8571,"timestamp":1745538866686},"volumeRatio":0.822375,"impliedVol":0.5195,"impliedVolPercentile":0.348},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","floatShares":46016259,"roa":"28.66%","roe":"54.39%","lyrEps":4.469732,"volumeRatio":0.822375,"shares":61384289,"dividePrice":0,"high":46.06,"amplitude":0.038778,"preClose":46.16,"low":44.27,"week52Low":24.22,"pbRate":"4.08","psRate":"6.34","week52High":60.6,"institutionHeld":0,"latestPrice":44.85,"eps":4.229999,"divideRate":0,"volume":859924,"delay":0,"ttmEps":4.229999,"open":45.96,"prevYearClose":38.6,"prevWeekClose":46.28,"prevMonthClose":48.36,"prevQuarterClose":48.36,"fiveDayClose":45.8,"twentyDayClose":49.56,"sixtyDayClose":37.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTGX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WLFC","MCHP","ADM","TKO","RKT","STSS","FENC","LU0889565833.HKD","TSYW.SI","BK4607","SMC","LU0048584097.USD","FBIO","BK4599","PTGX","PRMB","WSM","DASH","NOW","NOVA","BECN","RDFN","LU0354030511.USD","CKPT","REGN","ALKT","BKKT","IH","CME","EXE","SXTC","HUT","ENPH","W","DXCM","ABNB","CBRL","MLYS","MNDR","LU0289739699.SGD","TRVI","NEM"],"gpt_icon":1},{"id":"2518494274","title":"Protagonist Therapeutics Inc : Btig Raises Target Price to $82 From $73","url":"https://stock-news.laohu8.com/highlight/detail?id=2518494274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518494274?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:47","pubTimestamp":1741621643,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518222025","title":"Truist Securities Adjusts Price Target on Protagonist Therapeutics to $76 From $60, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518222025?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:53","pubTimestamp":1741614816,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) has an average rating of buy and mean price target of $59.91, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTGX"],"gpt_icon":0},{"id":"2518226812","title":"Protagonist Therapeutics Shares Rise After Positive Trial Data for Icotronkinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226812","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226812?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:44","pubTimestamp":1741614240,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics shares were up 28% to $49.25 after the company reported positive topline results from a Phase 2b study of icotrokinra, conducted by partner Johnson & Johnson.The biopharmaceutical company said icotrokinra is a targeted oral peptide that selectively blocks the IL-23 receptor in adults with moderately to severely active ulcerative colitis.Protagonist said the study met its primary endpoint of clinical response in all icotrokinra dose groups evaluated. The study also demonstrated clinically meaningful differences versus placebo in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12.Icotrokinra had a response rate of 63.5% for patients treated with the highest dose at week 12, versus 27% for placebo. Clinical remission and response rates continued to improve through week 28.Icotrokinra was well tolerated with the proportions of participants reporting one or more adverse events being similar between the icotroki","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","LU1935042991.SGD","LU1674673428.USD","LU2129689431.USD","LU1718418525.SGD","LU1732800096.USD","LU2592432038.USD","LU1674673691.USD","LU0234572021.USD","IE00B42XCP33.USD","BK4139","LU2129689605.HKD","LU1914381329.SGD","BK4581","LU1585245621.USD","LU0912757837.SGD","LU0058720904.USD","LU0795875086.SGD","LU1894683264.USD","BK4592","LU0320765646.SGD","JNJ","LU1032466523.USD","LU2430703251.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU1244550494.USD","IE00BDGV0183.EUR","SG9999002224.SGD","BK4585","LU0889566641.SGD","LU0882574055.USD","LU2112291526.USD","IE00B1BXHZ80.USD","LU0640476718.USD","LU1221951046.USD","LU2430703095.HKD","LU0122379950.USD","LU1221951129.SGD","BK4559","IE0009355771.USD","IE00B2B36J28.USD","PTGX","BK4532","LU1430594728.SGD","LU0345770308.USD","LU1066051498.USD","LU0345769128.USD","LU2347655156.SGD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2518224920","title":"BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518224920?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:38","pubTimestamp":1741613898,"startTime":"0","endTime":"0","summary":"BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study ** Drug developer Protagonist Therapeutics' PTGX.O shares rise 30.4% to $50.02** PTGX says the mid-stage study of all three doses of once-daily experimental drug, icotrokinra, conducted by its collaboration partner Johnson & Johnson JNJ.N met its main goal in patients with ulcerative colitis** Ulcerative colitis, a form of inflammatory bowel disease , is a condition in which the lining of the large intestine  and rectum become inflamed** Co says the study showed significant improvements over placebo in clinical recovery, symptom relief, and showed reduction in signs of disease severity within 12 weeks** Co says the study achieved a response rate of 63.5% vs 27% for placebo** PTGX had risen 24.2% in the past 12 months, as of last close  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1935042991.SGD","BK4139","LU2129689514.USD","LU1066051811.HKD","LU1718418525.SGD","LU2602419157.SGD","LU0320765646.SGD","IE0002141913.USD","IE00BDGV0183.EUR","IE00B3PB1722.GBP","LU1674673691.USD","LU1674673428.USD","PTGX","BK4534","LU0889566641.SGD","LU1280957306.USD","LU0345769128.USD","JNJ","LU0882574055.USD","LU0345770993.USD","BK4532","IE00BJT1NW94.SGD","BK4592","BK4007","BK4504","IE00B19Z3B42.SGD","LU0912757837.SGD","LU1059921491.USD","LU1057294990.SGD","LU1244550577.SGD","LU0795875169.SGD","LU1430594728.SGD","BK4559","LU1162221912.USD","IE0034235303.USD","BK4588","LU2505996681.GBP","LU1506573853.SGD","BK4585","IE00BVYPNV92.GBP","LU1221951129.SGD","LU1894683348.USD","LU0466842654.USD","LU0058720904.USD","SG9999001440.SGD","LU1732799900.SGD","LU2592432038.USD","LU0345769631.USD","SG9999002224.SGD","LU1023059063.AUD"],"gpt_icon":0},{"id":"2518220457","title":"Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220457","media":"Blockhead","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220457?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:37","pubTimestamp":1741613866,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/protagonist-therapeutics-bristol-myers-squibb-plaque-psoriasis/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU0456855351.SGD","LU2242652126.USD","BK4534","LU0061475181.USD","PTGX","BK4592","BK4504","LU0345770993.USD","IE00BGHQF631.EUR","BK4585","BK4533","LU1244550221.USD","LU1244550494.USD","BK4139","LU1059921491.USD","IE0002141913.USD","IE00B19Z3B42.SGD","LU0225284248.USD","LU1674673428.USD","LU1778281490.HKD","IE00BFTCPJ56.SGD","LU1221951129.SGD","IE0002270589.USD","LU0889566641.SGD","LU1291159041.SGD","LU1023059063.AUD","LU1066051811.HKD","LU1162221912.USD","LU1506573853.SGD","LU1989771016.USD","LU0096364046.USD","IE0034235303.USD","LU2112291526.USD","LU2430703178.SGD","LU0203347892.USD","JNJ","LU2242646821.SGD","LU0234570918.USD","BMY","LU0289739699.SGD","LU2125154935.USD","LU1267930813.SGD","IE00B7SZLL34.SGD","LU2347655156.SGD","IE00B4R5TH58.HKD","LU0792757196.USD","LU0321505439.SGD","LU1732799900.SGD","LU0985481810.HKD","BK4588"],"gpt_icon":1},{"id":"2518846225","title":"Protagonist Reports Positive Top Line Results From Phase 2B Study of Icotrokinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518846225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518846225?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518819225","title":"Protagonist : Results From Phase 2B Study of Icotrokinra Showing Potential to Transform Treatment Paradigm for Patients With Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2518819225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518819225?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518258422","title":"Protagonist Therapeutics : All Three Doses Met the Primary Endpoint of Clinical Response at Week 12, With a Favorable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258422","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518258422?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PTGX"],"gpt_icon":0},{"id":"2518226539","title":"Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226539","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226539?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:15","pubTimestamp":1741608900,"startTime":"0","endTime":"0","summary":"Clinical response rate of 63.5% and clinical remission rate of 30.2% achieved at Week 12 with the highest dose, which continued to improve through Week 28. All three doses met the primary endpoint of clinical response at Week 12, with a favorable safety profile. These results in ulcerative colitis build on strong data recently reported for the plaque psoriasis Phase 3 program. NEWARK, CALIFORNIA / ACCESS Newswire / March 10, 2025 / Protagonist Therapeutics, Inc.  today announced positive topline results from ANTHEM-UC, a Phase 2b study of icotrokinra , the first investigational targeted oral peptide that selectively blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis . The study conducted by Protagonist's collaboration partner, Johnson & Johnson, met its primary endpoint of clinical responsea in all icotrokinra dose groups evaluated. Additionally, the study demonstrated clinically meaningful differences versus placebo in key secondary endpoints of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-reports-positive-top-line-121500609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739699.SGD","LU2347655156.SGD","LU0122379950.USD","LU2602419157.SGD","BK4139","LU2129689514.USD","LU1244550494.USD","LU1674673691.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2592432038.USD","LU0345769128.USD","PTGX","LU0889566641.SGD","BK4504","LU1057294990.SGD","LU1244550221.USD","LU1066051811.HKD","IE00B42XCP33.USD","LU1914381329.SGD","LU1059921491.USD","BK4581","LU2129689431.USD","IE00B19Z3B42.SGD","LU0466842654.USD","IE0009355771.USD","LU0345770993.USD","BK4585","LU0203347892.USD","LU0795875169.SGD","LU0114720955.EUR","LU1894683348.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","BK4007","LU1066051498.USD","LU1894683264.USD","LU1261432733.SGD","IE000M9KFDE8.USD","BK4588","IE00BVYPNV92.GBP","BK4592","LU1032466523.USD","IE00BJT1NW94.SGD","LU0345769631.USD","IE00B19Z3581.USD","LU0203345920.USD","LU0320765646.SGD","JNJ","LU0058720904.USD"],"gpt_icon":0},{"id":"2518624799","title":"Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518624799","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518624799?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:27","pubTimestamp":1741606020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 10, 2025 07:27 ET (11:27 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2518266971","title":"Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518266971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518266971?lang=en_us&edition=fundamental","pubTime":"2025-03-10 12:35","pubTimestamp":1741581334,"startTime":"0","endTime":"0","summary":"Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Protagonist Therapeutics (PTGX – Research Report). The associated p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-market-potential-of-icotrokinra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-market-potential-of-icotrokinra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2518230558","title":"Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Halozyme (HALO) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518230558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518230558?lang=en_us&edition=fundamental","pubTime":"2025-03-10 08:21","pubTimestamp":1741566079,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Protagonist Therapeutics (PTGX – Research Report), H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-protagonist-therapeutics-ptgx-halozyme-halo-and-arcturus-therapeutics-arct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-protagonist-therapeutics-ptgx-halozyme-halo-and-arcturus-therapeutics-arct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARCT","BK4137","PTGX","HCSG","BK4139","HALO","LU0053671581.USD"],"gpt_icon":0},{"id":"2516789326","title":"Protagonist Therapeutics Is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2516789326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516789326?lang=en_us&edition=fundamental","pubTime":"2025-03-04 20:12","pubTimestamp":1741090320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 04, 2025 07:12 ET (12:12 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2516668204","title":"Protagonist Therapeutics: Positive VERIFY Trial Results and Promising Financial Prospects Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516668204?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:05","pubTimestamp":1741032326,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Julian Harr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-positive-verify-trial-results-and-promising-financial-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-positive-verify-trial-results-and-promising-financial-prospects-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2516166827","title":"Protagonist Therapeutics price target raised to $73 from $67 at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2516166827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516166827?lang=en_us&edition=fundamental","pubTime":"2025-03-04 04:00","pubTimestamp":1741032052,"startTime":"0","endTime":"0","summary":"BTIG raised the firm’s price target on Protagonist Therapeutics (PTGX) to $73 from $67 and keeps a Buy rating on the shares. Positive VERIFY data w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-price-target-raised-to-73-from-67-at-btig?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-price-target-raised-to-73-from-67-at-btig?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2516654002","title":"News Flash: 10 Analysts Think Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Earnings Are Under Threat","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654002","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516654002?lang=en_us&edition=fundamental","pubTime":"2025-03-04 02:18","pubTimestamp":1741025929,"startTime":"0","endTime":"0","summary":"The latest analyst coverage could presage a bad day for Protagonist Therapeutics, Inc. , with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. Both revenue and earnings per share  forecasts went under the knife, suggesting the analysts have soured majorly on the business. At US$37.59, shares are up 4.4% in the past 7 days. Investors could be forgiven for changing their mind on the business following the downgrade; but it's not clear if the revised forecasts will lead to selling activity.Check out our latest analysis for Protagonist Therapeutics. Even so, the longer term trajectory of the business is much more important for the value creation of shareholders. We have estimates - from multiple Protagonist Therapeutics analysts -","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/news-flash-10-analysts-think-181849388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","NDAQ","PTGX"],"gpt_icon":0},{"id":"2516651557","title":"Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651557?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:51","pubTimestamp":1741024260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 12:51 ET (17:51 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2516651448","title":"Protagonist Therapeutics’ Rusfertide: A Promising Blockbuster in the Polycythemia Vera Market with Strong Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651448","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516651448?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:45","pubTimestamp":1741023923,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Douglas Tsa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-rusfertide-a-promising-blockbuster-in-the-polycythemia-vera-market-with-strong-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-rusfertide-a-promising-blockbuster-in-the-polycythemia-vera-market-with-strong-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2516772656","title":"Takeda-Protagonist Therapeutics Partnered Investigational Drug Hits Primary Goal In Late-Stage Study In Patients With Type Of Blood Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2516772656","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516772656?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:01","pubTimestamp":1741021301,"startTime":"0","endTime":"0","summary":"On Monday, Protagonist Therapeutics, Inc.  and Takeda Pharmaceutical Co Ltd  released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.Polycythemia vera isa type of blood cancer. It causes your bone marrow to make too many red blood cells.Also Read: Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights. The study met its primary endpoint and all four key secondary endpoints. Rusfertide is a first-in-class investigational hepcidin mimetic peptide therapeutic, which has received FDA Orphan Drug and Fast Track designations.The study’s primary endpoint was the proportion of patients achieving a response, which was defined as the absence of phlebotomy eligibility.The first key secondary endpoint, which is the pre-specified primary endpoint for European Union  regulators, was also met, with a mean of 0.5 phlebotomies per patient in the rusfertide arm compared to 1.8 phlebotomies per patient in the placebo arm during weeks 0-32","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-protagonist-therapeutics-partnered-investigational-170141358.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4156","SSI","PTGX","BK4139","TAK"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":137,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-21","symbol":"PTGX","fiscalQuarterEnding":"2024/12","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740114000000,"reportTimeType":"pre","actualEps":1.98},{"market":"US","date":"2024-11-07","symbol":"PTGX","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-08-06","symbol":"PTGX","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-05-07","symbol":"PTGX","fiscalQuarterEnding":"2024/03","expectedEps":2.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":3.26},{"market":"US","date":"2024-02-27","symbol":"PTGX","fiscalQuarterEnding":"2023/12","expectedEps":-0.16,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709010000000,"reportTimeType":"post","actualEps":0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1733457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTGX","date":"2025-04-23","current":10.227443,"percent":0.841334,"low":-33.150526,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"high":16.785419,"avg":-6.962825,"sd":11.454081,"marketCap":2814469650},"quantilePoints":[{"date":"2020-04-24","current":-2.31386,"twenty":-9.48245,"median":-6.563586,"eighty":-4.76622,"marketCap":178599929},{"date":"2020-05-01","current":-2.352958,"twenty":-9.464922,"median":-6.446467,"eighty":-4.740135,"marketCap":181617747},{"date":"2020-05-08","current":-4.684392,"twenty":-9.456071,"median":-6.428145,"eighty":-4.726782,"marketCap":389572811},{"date":"2020-05-15","current":-6.707737,"twenty":-9.449125,"median":-6.436152,"eighty":-4.732566,"marketCap":557842221},{"date":"2020-05-22","current":-6.558676,"twenty":-9.437297,"median":-6.450252,"eighty":-4.737728,"marketCap":545445727},{"date":"2020-05-29","current":-6.844376,"twenty":-9.404895,"median":-6.539813,"eighty":-4.739024,"marketCap":569205673},{"date":"2020-06-05","current":-6.645628,"twenty":-9.379081,"median":-6.581449,"eighty":-4.739913,"marketCap":552677015},{"date":"2020-06-12","current":-6.699456,"twenty":-9.369673,"median":-6.614018,"eighty":-4.746872,"marketCap":557153526},{"date":"2020-06-19","current":-7.221168,"twenty":-9.365493,"median":-6.624925,"eighty":-4.756206,"marketCap":600541255},{"date":"2020-06-26","current":-7.676632,"twenty":-9.359153,"median":-6.653909,"eighty":-4.76292,"marketCap":638419430},{"date":"2020-07-02","current":-7.349526,"twenty":-9.350483,"median":-6.665119,"eighty":-4.765699,"marketCap":611216013},{"date":"2020-07-10","current":-6.745002,"twenty":-9.340032,"median":-6.693722,"eighty":-4.773141,"marketCap":560941344},{"date":"2020-07-17","current":-6.844376,"twenty":-9.31652,"median":-6.693867,"eighty":-4.786321,"marketCap":569205673},{"date":"2020-07-24","current":-6.409615,"twenty":-9.287585,"median":-6.699456,"eighty":-4.791108,"marketCap":533049233},{"date":"2020-07-31","current":-6.51313,"twenty":-9.266951,"median":-6.696733,"eighty":-4.791108,"marketCap":541657909},{"date":"2020-08-07","current":-9.004942,"twenty":-9.227278,"median":-6.701526,"eighty":-4.792704,"marketCap":661061766},{"date":"2020-08-14","current":-7.866789,"twenty":-9.208129,"median":-6.711877,"eighty":-4.798289,"marketCap":577508859},{"date":"2020-08-21","current":-10.519136,"twenty":-9.266951,"median":-6.719534,"eighty":-4.805114,"marketCap":772220259},{"date":"2020-08-28","current":-11.180969,"twenty":-9.350483,"median":-6.73258,"eighty":-4.808526,"marketCap":820806090},{"date":"2020-09-04","current":-10.288497,"twenty":-9.381064,"median":-6.745002,"eighty":-4.811454,"marketCap":755288832},{"date":"2020-09-11","current":-9.972622,"twenty":-9.453356,"median":-6.771156,"eighty":-4.817284,"marketCap":732100140},{"date":"2020-09-18","current":-11.030552,"twenty":-9.502467,"median":-6.779905,"eighty":-4.826262,"marketCap":809763856},{"date":"2020-09-25","current":-10.012733,"twenty":-9.579365,"median":-6.812626,"eighty":-4.827262,"marketCap":735044736},{"date":"2020-10-02","current":-10.283483,"twenty":-9.720678,"median":-6.825377,"eighty":-4.832331,"marketCap":754920758},{"date":"2020-10-09","current":-10.599358,"twenty":-9.834076,"median":-6.831954,"eighty":-4.838822,"marketCap":778109450},{"date":"2020-10-16","current":-10.438913,"twenty":-9.890916,"median":-6.842306,"eighty":-4.842911,"marketCap":766331067},{"date":"2020-10-23","current":-10.002705,"twenty":-9.954868,"median":-6.848516,"eighty":-4.844301,"marketCap":734308587},{"date":"2020-10-30","current":-9.501316,"twenty":-9.954868,"median":-6.855538,"eighty":-4.84986,"marketCap":697501139},{"date":"2020-11-06","current":-12.570131,"twenty":-9.996688,"median":-6.883005,"eighty":-4.85125,"marketCap":814104533},{"date":"2020-11-13","current":-13.119484,"twenty":-10.043212,"median":-6.902064,"eighty":-4.857232,"marketCap":849683350},{"date":"2020-11-20","current":-12.835947,"twenty":-10.069639,"median":-6.909829,"eighty":-4.859892,"marketCap":831320090},{"date":"2020-11-27","current":-14.088234,"twenty":-10.133066,"median":-6.931328,"eighty":-4.863756,"marketCap":912424489},{"date":"2020-12-04","current":-13.23467,"twenty":-10.191167,"median":-6.947788,"eighty":-4.866904,"marketCap":857143424},{"date":"2020-12-11","current":-12.711899,"twenty":-10.248386,"median":-6.951835,"eighty":-4.870704,"marketCap":823286163},{"date":"2020-12-18","current":-14.028485,"twenty":-10.288497,"median":-6.96474,"eighty":-4.870704,"marketCap":908554859},{"date":"2020-12-24","current":-15.775404,"twenty":-10.372775,"median":-6.983794,"eighty":-4.874047,"marketCap":1021694030},{"date":"2020-12-31","current":-13.390827,"twenty":-10.427646,"median":-7.004819,"eighty":-4.876544,"marketCap":867256911},{"date":"2021-01-08","current":-13.716298,"twenty":-10.516128,"median":-7.024491,"eighty":-4.884694,"marketCap":888336072},{"date":"2021-01-15","current":-16.187225,"twenty":-10.554233,"median":-7.0866,"eighty":-4.894853,"marketCap":1048365621},{"date":"2021-01-22","current":-14.852128,"twenty":-10.591336,"median":-7.135435,"eighty":-4.901178,"marketCap":961898042},{"date":"2021-01-29","current":-13.756152,"twenty":-10.619413,"median":-7.158325,"eighty":-4.905297,"marketCap":890917194},{"date":"2021-02-05","current":-14.865412,"twenty":-10.704851,"median":-7.200905,"eighty":-4.911244,"marketCap":962758416},{"date":"2021-02-12","current":-17.362908,"twenty":-10.770833,"median":-7.218551,"eighty":-4.922482,"marketCap":1124508713},{"date":"2021-02-19","current":-17.024152,"twenty":-10.799869,"median":-7.241871,"eighty":-4.92629,"marketCap":1102569178},{"date":"2021-02-26","current":-15.655843,"twenty":-10.882835,"median":-7.247939,"eighty":-4.927782,"marketCap":1013950664},{"date":"2021-03-05","current":-19.342306,"twenty":-10.94369,"median":-7.26205,"eighty":-4.93554,"marketCap":1252704427},{"date":"2021-03-12","current":-20.52997,"twenty":-11.026541,"median":-7.301179,"eighty":-4.944648,"marketCap":1358057548},{"date":"2021-03-19","current":-20.629309,"twenty":-11.096898,"median":-7.312261,"eighty":-4.952769,"marketCap":1364628794},{"date":"2021-03-26","current":-18.020016,"twenty":-11.193984,"median":-7.333401,"eighty":-4.954083,"marketCap":1192024060},{"date":"2021-04-01","current":-17.688887,"twenty":-11.231108,"median":-7.344739,"eighty":-4.954083,"marketCap":1170119906},{"date":"2021-04-09","current":-17.602794,"twenty":-11.41166,"median":-7.360757,"eighty":-4.954083,"marketCap":1164424826},{"date":"2021-04-16","current":-17.63548,"twenty":-11.516633,"median":-7.38668,"eighty":-4.961031,"marketCap":1166586981},{"date":"2021-04-23","current":-19.309356,"twenty":-11.594149,"median":-7.421229,"eighty":-4.962647,"marketCap":1277313881},{"date":"2021-04-30","current":-19.223005,"twenty":-11.691477,"median":-7.444978,"eighty":-4.963904,"marketCap":1271601779},{"date":"2021-05-07","current":-18.301078,"twenty":-11.75763,"median":-7.473566,"eighty":-4.967979,"marketCap":1282319943},{"date":"2021-05-14","current":-19.110139,"twenty":-11.88162,"median":-7.483013,"eighty":-4.967979,"marketCap":1339009208},{"date":"2021-05-21","current":-21.49969,"twenty":-11.947151,"median":-7.506443,"eighty":-4.974928,"marketCap":1506440290},{"date":"2021-05-28","current":-22.020249,"twenty":-11.985902,"median":-7.534801,"eighty":-4.976672,"marketCap":1542914778},{"date":"2021-06-04","current":-21.832095,"twenty":-12.059638,"median":-7.548308,"eighty":-4.980835,"marketCap":1529731228},{"date":"2021-06-11","current":-24.861369,"twenty":-12.389994,"median":-7.587616,"eighty":-4.993626,"marketCap":1741986380},{"date":"2021-06-18","current":-28.48276,"twenty":-12.537035,"median":-7.597798,"eighty":-4.997154,"marketCap":1995730024},{"date":"2021-06-25","current":-29.247308,"twenty":-12.582661,"median":-7.600475,"eighty":-5.001637,"marketCap":2049300361},{"date":"2021-07-02","current":-31.091612,"twenty":-12.701939,"median":-7.651717,"eighty":-5.008279,"marketCap":2178527052},{"date":"2021-07-09","current":-30.9776,"twenty":-12.711899,"median":-7.67129,"eighty":-5.009669,"marketCap":2170538493},{"date":"2021-07-16","current":-30.729458,"twenty":-12.777141,"median":-7.687868,"eighty":-5.009724,"marketCap":2153151629},{"date":"2021-07-23","current":-31.534245,"twenty":-12.933061,"median":-7.7092,"eighty":-5.010215,"marketCap":2209541458},{"date":"2021-07-30","current":-33.150526,"twenty":-13.021304,"median":-7.726424,"eighty":-5.012424,"marketCap":2322791031},{"date":"2021-08-06","current":-28.073213,"twenty":-13.121745,"median":-7.74057,"eighty":-5.014773,"marketCap":2287658067},{"date":"2021-08-13","current":-27.828134,"twenty":-13.235716,"median":-7.773558,"eighty":-5.021266,"marketCap":2267686826},{"date":"2021-08-20","current":-28.720922,"twenty":-13.296243,"median":-7.792145,"eighty":-5.029659,"marketCap":2340439203},{"date":"2021-08-27","current":-27.933168,"twenty":-13.451458,"median":-7.801258,"eighty":-5.035552,"marketCap":2276245929},{"date":"2021-09-03","current":-28.522525,"twenty":-13.634575,"median":-7.822739,"eighty":-5.041631,"marketCap":2324272008},{"date":"2021-09-10","current":-26.305143,"twenty":-13.708328,"median":-7.836668,"eighty":-5.045214,"marketCap":2143579830},{"date":"2021-09-17","current":-10.22913,"twenty":-13.764123,"median":-7.855229,"eighty":-5.050099,"marketCap":833561544},{"date":"2021-09-24","current":-10.976037,"twenty":-13.742868,"median":-7.871118,"eighty":-5.056692,"marketCap":894426278},{"date":"2021-10-01","current":-10.474209,"twenty":-13.720284,"median":-7.892183,"eighty":-5.058339,"marketCap":853532785},{"date":"2021-10-08","current":-10.64343,"twenty":-13.708328,"median":-7.896506,"eighty":-5.059985,"marketCap":867322451},{"date":"2021-10-15","current":-18.071657,"twenty":-13.815403,"median":-7.923511,"eighty":-5.063529,"marketCap":1472641245},{"date":"2021-10-22","current":-18.065822,"twenty":-14.044427,"median":-7.940329,"eighty":-5.065985,"marketCap":1472165740},{"date":"2021-10-29","current":-18.182526,"twenty":-14.108193,"median":-7.965498,"eighty":-5.06708,"marketCap":1481675854},{"date":"2021-11-05","current":-14.975824,"twenty":-14.259226,"median":-7.972706,"eighty":-5.068568,"marketCap":1610350378},{"date":"2021-11-12","current":-16.467193,"twenty":-14.433745,"median":-7.975682,"eighty":-5.071361,"marketCap":1770717221},{"date":"2021-11-19","current":-15.548403,"twenty":-14.860098,"median":-7.984462,"eighty":-5.076877,"marketCap":1671919791},{"date":"2021-11-26","current":-14.762772,"twenty":-15.018434,"median":-8.001658,"eighty":-5.084697,"marketCap":1587440830},{"date":"2021-12-03","current":-14.323351,"twenty":-14.965171,"median":-8.023507,"eighty":-5.090214,"marketCap":1540189885},{"date":"2021-12-10","current":-14.119175,"twenty":-15.004231,"median":-8.049664,"eighty":-5.09948,"marketCap":1518234900},{"date":"2021-12-17","current":-13.475579,"twenty":-14.965171,"median":-8.10968,"eighty":-5.100086,"marketCap":1449028971},{"date":"2021-12-23","current":-15.202193,"twenty":-14.975824,"median":-8.126854,"eighty":-5.100445,"marketCap":1634691774},{"date":"2021-12-31","current":-15.18,"twenty":-15.108982,"median":-8.143408,"eighty":-5.105061,"marketCap":1632305363},{"date":"2022-01-07","current":-15.472947,"twenty":-15.18,"median":-8.170847,"eighty":-5.105061,"marketCap":1663805993},{"date":"2022-01-14","current":-15.961193,"twenty":-15.310445,"median":-8.220609,"eighty":-5.107204,"marketCap":1716307042},{"date":"2022-01-21","current":-13.018403,"twenty":-15.313651,"median":-8.244628,"eighty":-5.11179,"marketCap":1399868897},{"date":"2022-01-28","current":-12.494649,"twenty":-15.270004,"median":-8.259405,"eighty":-5.112936,"marketCap":1343549590},{"date":"2022-02-04","current":-12.534596,"twenty":-15.220835,"median":-8.287857,"eighty":-5.134046,"marketCap":1347845130},{"date":"2022-02-11","current":-12.361491,"twenty":-15.203968,"median":-8.33787,"eighty":-5.153028,"marketCap":1329231121},{"date":"2022-02-18","current":-11.029912,"twenty":-15.202193,"median":-8.359941,"eighty":-5.157029,"marketCap":1186046440},{"date":"2022-02-25","current":-10.870123,"twenty":-15.188877,"median":-8.37967,"eighty":-5.160387,"marketCap":1168864279},{"date":"2022-03-04","current":-9.374147,"twenty":-15.178559,"median":-8.389798,"eighty":-5.170868,"marketCap":1176933522},{"date":"2022-03-11","current":-9.836877,"twenty":-15.098329,"median":-8.39452,"eighty":-5.173647,"marketCap":1235029788},{"date":"2022-03-18","current":-10.480844,"twenty":-14.876842,"median":-8.39452,"eighty":-5.173647,"marketCap":1315880424},{"date":"2022-03-25","current":-9.624793,"twenty":-14.566387,"median":-8.39452,"eighty":-5.173647,"marketCap":1208402332},{"date":"2022-04-01","current":-9.324018,"twenty":-14.424835,"median":-8.39452,"eighty":-5.173647,"marketCap":1170639759},{"date":"2022-04-08","current":-9.70577,"twenty":-14.310208,"median":-8.39452,"eighty":-5.173647,"marketCap":1218569179},{"date":"2022-04-14","current":-7.714908,"twenty":-14.18041,"median":-8.386442,"eighty":-5.173647,"marketCap":968614434},{"date":"2022-04-22","current":-7.312727,"twenty":-14.094448,"median":-8.352792,"eighty":-5.173647,"marketCap":918120248},{"date":"2022-04-29","current":-3.515214,"twenty":-14.033799,"median":-8.271595,"eighty":-5.134046,"marketCap":441338607},{"date":"2022-05-06","current":-3.614961,"twenty":-13.758809,"median":-8.235986,"eighty":-5.104138,"marketCap":442771319},{"date":"2022-05-13","current":-3.499759,"twenty":-13.724069,"median":-8.198163,"eighty":-5.081552,"marketCap":428661025},{"date":"2022-05-20","current":-3.146208,"twenty":-13.724069,"median":-8.198163,"eighty":-5.06468,"marketCap":385357016},{"date":"2022-05-27","current":-3.535512,"twenty":-13.724069,"median":-8.198163,"eighty":-5.046019,"marketCap":433040082},{"date":"2022-06-03","current":-3.654686,"twenty":-13.724069,"median":-8.178259,"eighty":-5.023191,"marketCap":447636938},{"date":"2022-06-10","current":-2.911832,"twenty":-13.724069,"median":-8.178259,"eighty":-5.009669,"marketCap":356649865},{"date":"2022-06-17","current":-3.122373,"twenty":-13.724069,"median":-8.178259,"eighty":-4.980835,"marketCap":382437645},{"date":"2022-06-24","current":-3.607016,"twenty":-13.725196,"median":-8.136316,"eighty":-4.966349,"marketCap":441798196},{"date":"2022-07-01","current":-3.122373,"twenty":-13.725196,"median":-8.111134,"eighty":-4.954083,"marketCap":382437645},{"date":"2022-07-08","current":-3.821531,"twenty":-13.725196,"median":-8.06172,"eighty":-4.930766,"marketCap":468072538},{"date":"2022-07-15","current":-3.757971,"twenty":-13.725196,"median":-7.987171,"eighty":-4.902518,"marketCap":460287547},{"date":"2022-07-22","current":-3.93276,"twenty":-13.725196,"median":-7.971801,"eighty":-4.870704,"marketCap":481696271},{"date":"2022-07-29","current":-3.952623,"twenty":-13.725196,"median":-7.937326,"eighty":-4.854029,"marketCap":484129080},{"date":"2022-08-05","current":-4.239613,"twenty":-13.725196,"median":-7.919184,"eighty":-4.835066,"marketCap":562503419},{"date":"2022-08-12","current":-4.217416,"twenty":-13.725196,"median":-7.896506,"eighty":-4.808704,"marketCap":559558375},{"date":"2022-08-19","current":-3.536711,"twenty":-13.725196,"median":-7.896506,"eighty":-4.791108,"marketCap":469243690},{"date":"2022-08-26","current":-3.451622,"twenty":-13.725196,"median":-7.89352,"eighty":-4.756206,"marketCap":457954354},{"date":"2022-09-02","current":-3.274047,"twenty":-13.725196,"median":-7.821543,"eighty":-4.731245,"marketCap":434394001},{"date":"2022-09-09","current":-3.270347,"twenty":-13.725196,"median":-7.786399,"eighty":-4.687787,"marketCap":433903161},{"date":"2022-09-16","current":-3.092772,"twenty":-13.725196,"median":-7.737759,"eighty":-4.625933,"marketCap":410342808},{"date":"2022-09-23","current":-3.077974,"twenty":-13.725196,"median":-7.700362,"eighty":-4.571699,"marketCap":408379445},{"date":"2022-09-30","current":-3.118668,"twenty":-13.725196,"median":-7.641433,"eighty":-4.473266,"marketCap":413778693},{"date":"2022-10-07","current":-3.074275,"twenty":-13.725196,"median":-7.556602,"eighty":-4.390662,"marketCap":407888605},{"date":"2022-10-14","current":-2.955891,"twenty":-13.725196,"median":-7.482881,"eighty":-4.270343,"marketCap":392181703},{"date":"2022-10-21","current":-3.052078,"twenty":-13.725196,"median":-7.389679,"eighty":-4.207058,"marketCap":404943561},{"date":"2022-10-28","current":-3.174161,"twenty":-13.725196,"median":-7.329698,"eighty":-4.07704,"marketCap":421141303},{"date":"2022-11-04","current":-2.915197,"twenty":-13.725196,"median":-7.297769,"eighty":-4.001892,"marketCap":386782455},{"date":"2022-11-11","current":-3.206636,"twenty":-13.725196,"median":-7.245724,"eighty":-3.947357,"marketCap":417202525},{"date":"2022-11-18","current":-3.055379,"twenty":-13.725196,"median":-7.201344,"eighty":-3.902686,"marketCap":397523160},{"date":"2022-11-25","current":-2.873871,"twenty":-13.725196,"median":-7.138357,"eighty":-3.883416,"marketCap":373907923},{"date":"2022-12-02","current":-3.051598,"twenty":-13.725196,"median":-7.024491,"eighty":-3.813471,"marketCap":397031176},{"date":"2022-12-09","current":-2.862527,"twenty":-13.725196,"median":-6.972734,"eighty":-3.760354,"marketCap":372431971},{"date":"2022-12-16","current":-3.667968,"twenty":-13.725196,"median":-6.94375,"eighty":-3.7496,"marketCap":477224586},{"date":"2022-12-23","current":-3.815443,"twenty":-13.725196,"median":-6.908816,"eighty":-3.718259,"marketCap":496411966},{"date":"2022-12-30","current":-4.125518,"twenty":-13.725196,"median":-6.883005,"eighty":-3.718259,"marketCap":536754664},{"date":"2023-01-06","current":-4.412905,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":574145456},{"date":"2023-01-13","current":-4.601976,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":598744661},{"date":"2023-01-20","current":-4.409124,"twenty":-13.725196,"median":-6.82294,"eighty":-3.718259,"marketCap":573653472},{"date":"2023-01-27","current":-5.101122,"twenty":-13.725196,"median":-6.776526,"eighty":-3.718259,"marketCap":663686564},{"date":"2023-02-03","current":-5.41876,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":705013229},{"date":"2023-02-10","current":-6.507806,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":846704653},{"date":"2023-02-17","current":-6.11454,"twenty":-13.725196,"median":-6.693722,"eighty":-3.718259,"marketCap":795538305},{"date":"2023-02-24","current":-6.379238,"twenty":-13.725196,"median":-6.663907,"eighty":-3.718259,"marketCap":829977193},{"date":"2023-03-03","current":-5.940595,"twenty":-13.725196,"median":-6.624925,"eighty":-3.718259,"marketCap":772907036},{"date":"2023-03-10","current":-9.453525,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1229960275},{"date":"2023-03-17","current":-9.023959,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1149589221},{"date":"2023-03-24","current":-8.343741,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1062934191},{"date":"2023-03-31","current":-9.257407,"twenty":-13.724069,"median":-6.653909,"eighty":-3.719583,"marketCap":1179328818},{"date":"2023-04-06","current":-7.686398,"twenty":-13.724069,"median":-6.682278,"eighty":-3.719583,"marketCap":979193321},{"date":"2023-04-14","current":-8.643758,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":1101154213},{"date":"2023-04-21","current":-10.23871,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":1304340024},{"date":"2023-04-28","current":-10.043772,"twenty":-13.725196,"median":-6.771156,"eighty":-3.718259,"marketCap":1279506203},{"date":"2023-05-05","current":-10.455801,"twenty":-13.725196,"median":-6.812626,"eighty":-3.718259,"marketCap":1331995870},{"date":"2023-05-12","current":-10.095379,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":1415250998},{"date":"2023-05-19","current":-10.226064,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":1433571400},{"date":"2023-05-26","current":-10.356748,"twenty":-13.726324,"median":-6.891609,"eighty":-3.716934,"marketCap":1451891801},{"date":"2023-06-02","current":-11.226617,"twenty":-13.726324,"median":-6.909323,"eighty":-3.716934,"marketCap":1573836972},{"date":"2023-06-09","current":-11.990305,"twenty":-13.726324,"median":-6.947793,"eighty":-3.716934,"marketCap":1680896817},{"date":"2023-06-16","current":-11.7126,"twenty":-13.727451,"median":-6.972734,"eighty":-3.71561,"marketCap":1641965964},{"date":"2023-06-23","current":-11.247036,"twenty":-13.728579,"median":-7.018276,"eighty":-3.714286,"marketCap":1576699535},{"date":"2023-06-30","current":-11.300127,"twenty":-13.734094,"median":-7.132514,"eighty":-3.713546,"marketCap":1584142198},{"date":"2023-07-07","current":-9.662487,"twenty":-13.734094,"median":-7.200466,"eighty":-3.713546,"marketCap":1354564669},{"date":"2023-07-14","current":-8.737485,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":1224890579},{"date":"2023-07-21","current":-8.126943,"twenty":-13.734094,"median":-7.285773,"eighty":-3.713546,"marketCap":1139299954},{"date":"2023-07-28","current":-7.669548,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":1075178550},{"date":"2023-08-04","current":-7.763453,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1068336593},{"date":"2023-08-11","current":-7.859608,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1081568549},{"date":"2023-08-18","current":-7.838705,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1078692037},{"date":"2023-08-25","current":-8.06446,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1109758368},{"date":"2023-09-01","current":-8.286034,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1140249396},{"date":"2023-09-08","current":-7.842886,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1079267339},{"date":"2023-09-15","current":-7.525157,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1035544356},{"date":"2023-09-22","current":-7.098731,"twenty":-13.734094,"median":-7.349526,"eighty":-3.713546,"marketCap":976863509},{"date":"2023-09-29","current":-7.161441,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":985493045},{"date":"2023-10-06","current":-6.785183,"twenty":-13.734094,"median":-7.297769,"eighty":-3.713546,"marketCap":933715827},{"date":"2023-10-13","current":-6.425648,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":884239819},{"date":"2023-10-19","current":-6.212435,"twenty":-13.734094,"median":-7.201344,"eighty":-3.713546,"marketCap":854899396},{"date":"2023-10-27","current":-5.940693,"twenty":-13.756152,"median":-7.161441,"eighty":-3.710587,"marketCap":817504738},{"date":"2023-11-03","current":-6.310619,"twenty":-13.756152,"median":-7.113513,"eighty":-3.710587,"marketCap":886541029},{"date":"2023-11-10","current":-6.174931,"twenty":-13.756152,"median":-7.024491,"eighty":-3.710587,"marketCap":867478954},{"date":"2023-11-17","current":-6.618343,"twenty":-13.756152,"median":-6.973312,"eighty":-3.710587,"marketCap":929771326},{"date":"2023-11-24","current":-7.074073,"twenty":-13.756152,"median":-7.012061,"eighty":-3.710587,"marketCap":993794042},{"date":"2023-12-01","current":-7.476429,"twenty":-13.756152,"median":-7.074073,"eighty":-3.710587,"marketCap":1050318601},{"date":"2023-12-08","current":-8.58496,"twenty":-13.750637,"median":-7.12048,"eighty":-3.711327,"marketCap":1206049531},{"date":"2023-12-15","current":-8.527481,"twenty":-13.750637,"median":-7.155703,"eighty":-3.711327,"marketCap":1197974593},{"date":"2023-12-22","current":-8.872357,"twenty":-13.750637,"median":-7.200905,"eighty":-3.711327,"marketCap":1246424216},{"date":"2023-12-29","current":-9.496419,"twenty":-13.756152,"median":-7.221168,"eighty":-3.710587,"marketCap":1334094961},{"date":"2024-01-05","current":-9.369143,"twenty":-13.758809,"median":-7.255861,"eighty":-3.710382,"marketCap":1316214744},{"date":"2024-01-12","current":-10.026051,"twenty":-13.758809,"median":-7.308825,"eighty":-3.710382,"marketCap":1408499739},{"date":"2024-01-19","current":-9.83719,"twenty":-13.761466,"median":-7.337105,"eighty":-3.710177,"marketCap":1381967803},{"date":"2024-01-26","current":-9.9891,"twenty":-13.758809,"median":-7.381258,"eighty":-3.710382,"marketCap":1403308708},{"date":"2024-02-02","current":-11.709376,"twenty":-13.758809,"median":-7.448718,"eighty":-3.710382,"marketCap":1644980039},{"date":"2024-02-09","current":-10.719909,"twenty":-13.758809,"median":-7.506951,"eighty":-3.710382,"marketCap":1505975765},{"date":"2024-02-16","current":-11.590312,"twenty":-13.758809,"median":-7.588064,"eighty":-3.710382,"marketCap":1628253384},{"date":"2024-02-23","current":-11.368606,"twenty":-13.758809,"median":-7.612358,"eighty":-3.710382,"marketCap":1597107198},{"date":"2024-03-01","current":-22.422829,"twenty":-13.846047,"median":-7.669548,"eighty":-3.710587,"marketCap":1770394439},{"date":"2024-03-08","current":-22.799249,"twenty":-14.088234,"median":-7.709105,"eighty":-3.710587,"marketCap":1800114688},{"date":"2024-03-15","current":-20.924529,"twenty":-14.167973,"median":-7.750912,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-22","current":-20.924529,"twenty":-14.310035,"median":-7.763453,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-28","current":-21.020479,"twenty":-14.42038,"median":-7.763453,"eighty":-3.710587,"marketCap":1659671943},{"date":"2024-04-05","current":-20.407874,"twenty":-14.566387,"median":-7.825595,"eighty":-3.710382,"marketCap":1611303694},{"date":"2024-04-12","current":-20.415255,"twenty":-14.876842,"median":-7.865289,"eighty":-3.710382,"marketCap":1611886444},{"date":"2024-04-19","current":-18.614343,"twenty":-15.098329,"median":-7.910185,"eighty":-3.710382,"marketCap":1469695449},{"date":"2024-04-26","current":-18.201019,"twenty":-15.18,"median":-7.996259,"eighty":-3.710587,"marketCap":1437061450},{"date":"2024-05-03","current":-18.969611,"twenty":-15.310445,"median":-8.088174,"eighty":-3.710587,"marketCap":1497745616},{"date":"2024-05-10","current":10.228214,"twenty":-15.330912,"median":-8.126943,"eighty":-3.694411,"marketCap":1658095799},{"date":"2024-05-17","current":11.556037,"twenty":-15.330912,"median":-8.126943,"eighty":-3.654686,"marketCap":1873349128},{"date":"2024-05-24","current":11.04951,"twenty":-15.330912,"median":-8.126943,"eighty":-3.622906,"marketCap":1791236141},{"date":"2024-05-31","current":10.025604,"twenty":-15.330912,"median":-8.126943,"eighty":-3.603684,"marketCap":1625250605},{"date":"2024-06-07","current":12.30859,"twenty":-15.330912,"median":-8.126943,"eighty":-3.535512,"marketCap":1995345564},{"date":"2024-06-14","current":12.427986,"twenty":-15.332132,"median":-8.135111,"eighty":-3.509824,"marketCap":2014700768},{"date":"2024-06-21","current":11.371517,"twenty":-15.333353,"median":-8.143279,"eighty":-3.48069,"marketCap":1843436540},{"date":"2024-06-28","current":11.534329,"twenty":-15.337014,"median":-8.157491,"eighty":-3.42031,"marketCap":1869830000},{"date":"2024-07-05","current":12.482256,"twenty":-15.337014,"median":-8.157491,"eighty":-3.39613,"marketCap":2023498588},{"date":"2024-07-12","current":12.948984,"twenty":-15.337014,"median":-8.157491,"eighty":-3.360722,"marketCap":2099159840},{"date":"2024-07-15","current":13.06838,"twenty":-15.337014,"median":-8.157491,"eighty":-3.35675,"marketCap":2118515043},{"date":"2024-08-02","current":13.7341,"twenty":-15.368196,"median":-8.262741,"eighty":-3.343328,"marketCap":2226434968},{"date":"2024-08-09","current":12.886266,"twenty":-15.368196,"median":-8.262741,"eighty":-3.288729,"marketCap":2190072470},{"date":"2024-08-16","current":14.068143,"twenty":-15.368196,"median":-8.262741,"eighty":-3.264428,"marketCap":2390937105},{"date":"2024-08-23","current":14.362745,"twenty":-15.368196,"median":-8.262741,"eighty":-3.236958,"marketCap":2441006002},{"date":"2024-08-30","current":14.657348,"twenty":-15.368196,"median":-8.262741,"eighty":-3.21123,"marketCap":2491074899},{"date":"2024-09-06","current":14.563768,"twenty":-15.368196,"median":-8.262741,"eighty":-3.182376,"marketCap":2475170661},{"date":"2024-09-13","current":15.821895,"twenty":-15.368196,"median":-8.262741,"eighty":-3.169466,"marketCap":2688994305},{"date":"2024-09-20","current":15.915474,"twenty":-15.368196,"median":-8.262741,"eighty":-3.139194,"marketCap":2704898543},{"date":"2024-09-27","current":15.572349,"twenty":-15.368196,"median":-8.262741,"eighty":-3.125331,"marketCap":2646583004},{"date":"2024-10-04","current":15.36786,"twenty":-15.368196,"median":-8.262741,"eighty":-3.113634,"marketCap":2611829298},{"date":"2024-10-11","current":15.107917,"twenty":-15.368196,"median":-8.262741,"eighty":-3.099754,"marketCap":2567650860},{"date":"2024-10-18","current":16.296725,"twenty":-15.368196,"median":-8.262741,"eighty":-3.090553,"marketCap":2769693586},{"date":"2024-10-25","current":16.272464,"twenty":-15.368196,"median":-8.262741,"eighty":-3.084958,"marketCap":2765570265},{"date":"2024-10-31","current":16.50468,"twenty":-15.368196,"median":-8.262741,"eighty":-3.065396,"marketCap":2805036337},{"date":"2024-11-08","current":16.414771,"twenty":-15.371747,"median":-8.266026,"eighty":-3.052078,"marketCap":2804447291},{"date":"2024-11-15","current":14.316166,"twenty":-15.371747,"median":-8.266026,"eighty":-3.040652,"marketCap":2445902658},{"date":"2024-11-22","current":14.528955,"twenty":-15.371747,"median":-8.266026,"eighty":-3.023767,"marketCap":2482257449},{"date":"2024-11-29","current":15.278949,"twenty":-15.371747,"median":-8.266026,"eighty":-3.003662,"marketCap":2610393188},{"date":"2024-12-06","current":14.53942,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2484045390},{"date":"2024-12-13","current":14.085935,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2406567966},{"date":"2024-12-20","current":13.792914,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2356505631},{"date":"2024-12-27","current":13.782449,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2354717691},{"date":"2025-01-03","current":13.597567,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2323130741},{"date":"2025-01-10","current":13.123152,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2242077437},{"date":"2025-01-17","current":12.746411,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2177711577},{"date":"2025-01-24","current":13.185942,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2252805080},{"date":"2025-01-31","current":13.646404,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2331474464},{"date":"2025-02-07","current":13.168501,"twenty":-15.375298,"median":-8.269311,"eighty":-2.991095,"marketCap":2249825179},{"date":"2025-02-14","current":13.492917,"twenty":-15.375298,"median":-8.269311,"eighty":-2.95959,"marketCap":2305251336},{"date":"2025-02-21","current":13.426638,"twenty":-15.375298,"median":-8.269311,"eighty":-2.9495,"marketCap":2293927712},{"date":"2025-02-28","current":8.106113,"twenty":-15.375298,"median":-8.269311,"eighty":-2.939639,"marketCap":2230705062},{"date":"2025-03-07","current":8.710614,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2397056485},{"date":"2025-03-14","current":12.246164,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3369997466},{"date":"2025-03-21","current":11.833498,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3256436531},{"date":"2025-03-28","current":11.02824,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3034839248},{"date":"2025-04-04","current":10.372434,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2854369438},{"date":"2025-04-11","current":9.12105,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2510003577},{"date":"2025-04-17","current":10.21629,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2811400436},{"date":"2025-04-23","current":10.227443,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2814469650}],"updateTime":1745517271425}}}